28May/13

Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic … – ThomasNet Industrial News Room (press release)

HLA Typing

Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic …
ThomasNet Industrial News Room (press release)
In February 2013, the 3500 Dx/3500xL Dx Genetic Analyzers CS2 Series received U.S. Food and Drug Administration (FDA) 510(k) clearance for use with the company’s SeCore® HLA typing kits. Additional products offered by Life Technologies for the …

and more »
24May/13

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic … – SelectScience.net (press release)

HLA Typing

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic …
SelectScience.net (press release)
In February 2013, the 3500 Dx/3500xL Dx Genetic Analyzers CS2 Series received U.S. Food and Drug Administration (FDA) 510(k) clearance for use with the company’s SeCore® HLA typing kits. Additional products offered by Life Technologies for the …
20May/13

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic … – Canada NewsWire (press release)

HLA Typing

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic …
Canada NewsWire (press release)
In February 2013, the 3500 Dx/3500xL Dx Genetic Analyzers CS2 Series received U.S. Food and Drug Administration (FDA) 510(k) clearance for use with the company’s SeCore® HLA typing kits. Additional products offered by Life Technologies for the …
20May/13

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic … – DigitalJournal.com (press release)

HLA Typing

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic …
DigitalJournal.com (press release)
In February 2013, the 3500 Dx/3500xL Dx Genetic Analyzers CS2 Series received U.S. Food and Drug Administration (FDA) 510(k) clearance for use with the company’s SeCore® HLA typing kits. Additional products offered by Life Technologies for the …

and more »
10May/13

Geisinger Partners with Indivumed for Personalized Medicine Initiative – Newswise – Newswise (press release)

HLA Typing

Geisinger Partners with Indivumed for Personalized Medicine Initiative – Newswise
Newswise (press release)
Indivumed follows highly standardized processes that enable the company to limit cold ischemia time – the time between removal of tissue from the body and the time it is preserved – to less than 10 minutes, guaranteeing tissue samples maintain their …

and more »